Insider Transactions in Q1 2021 at Emergent Bio Solutions Inc. (EBS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Sean Kirk EVP, Manufacturing & Tech Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
159
-0.89%
|
-
|
|
Mar 04
2021
|
Sue Bailey Director |
SELL
Open market or private sale
|
Direct |
8,168
-25.06%
|
$751,456
$92.37 P/Share
|
|
Mar 01
2021
|
Adam Havey EVP, Business Operations |
SELL
Open market or private sale
|
Direct |
37,279
-32.75%
|
$3,690,621
$99.32 P/Share
|
|
Mar 01
2021
|
Adam Havey EVP, Business Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
37,279
+24.66%
|
$1,491,160
$40.13 P/Share
|
|
Feb 26
2021
|
Richard S Lindahl EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
819
-2.11%
|
$79,443
$97.15 P/Share
|
|
Feb 26
2021
|
Katherine Strei EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,210
-1.87%
|
$117,370
$97.15 P/Share
|
|
Feb 26
2021
|
Atul Saran EVP, Chief Strat & Dev Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,563
-1.7%
|
$151,611
$97.15 P/Share
|
|
Feb 26
2021
|
Sean Kirk EVP, Manufacturing & Tech Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
621
-1.69%
|
-
|
|
Feb 26
2021
|
Robert Kramer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,576
-0.78%
|
$249,872
$97.15 P/Share
|
|
Feb 26
2021
|
Adam Havey EVP, Business Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,471
-1.87%
|
$142,687
$97.15 P/Share
|
|
Feb 24
2021
|
Richard S Lindahl EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,010
-2.54%
|
$93,930
$93.49 P/Share
|
|
Feb 24
2021
|
Richard S Lindahl EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,023
+9.62%
|
-
|
|
Feb 24
2021
|
Katherine Strei EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
619
-1.86%
|
$57,567
$93.49 P/Share
|
|
Feb 24
2021
|
Katherine Strei EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,348
+7.73%
|
-
|
|
Feb 24
2021
|
Atul Saran EVP, Chief Strat & Dev Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
887
-1.88%
|
$82,491
$93.49 P/Share
|
|
Feb 24
2021
|
Atul Saran EVP, Chief Strat & Dev Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,488
+7.64%
|
-
|
|
Feb 24
2021
|
Karen L. Smith EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,883
+21.78%
|
-
|
|
Feb 24
2021
|
Sean Kirk EVP, Manufacturing & Tech Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
433
-2.28%
|
-
|
|
Feb 24
2021
|
Sean Kirk EVP, Manufacturing & Tech Ops |
BUY
Grant, award, or other acquisition
|
Direct |
6,418
+15.68%
|
-
|
|
Feb 24
2021
|
Robert Kramer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,425
-1.44%
|
$225,525
$93.49 P/Share
|
|
Feb 24
2021
|
Robert Kramer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,950
+8.54%
|
-
|
|
Feb 24
2021
|
Adam Havey EVP, Business Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
847
-2.09%
|
$78,771
$93.49 P/Share
|
|
Feb 24
2021
|
Adam Havey EVP, Business Operations |
BUY
Grant, award, or other acquisition
|
Direct |
7,488
+8.85%
|
-
|
|
Feb 09
2021
|
Richard S Lindahl EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,522
-7.35%
|
$310,206
$123.45 P/Share
|
|
Feb 09
2021
|
Richard S Lindahl EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,495
+6.78%
|
-
|
|
Feb 09
2021
|
Katherine Strei EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,042
-6.8%
|
$251,166
$123.45 P/Share
|
|
Feb 09
2021
|
Katherine Strei EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,014
+6.29%
|
-
|
|
Feb 09
2021
|
Robert Kramer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,293
-1.51%
|
$528,039
$123.45 P/Share
|
|
Feb 09
2021
|
Robert Kramer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,281
+1.14%
|
-
|
|
Feb 09
2021
|
Atul Saran EVP, Chief Strat & Dev Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,430
-5.76%
|
$298,890
$123.45 P/Share
|
|
Feb 09
2021
|
Atul Saran EVP, Chief Strat & Dev Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,656
+5.93%
|
-
|
|
Feb 09
2021
|
Adam Havey EVP, Business Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-6.2%
|
$268,509
$123.45 P/Share
|
|
Feb 09
2021
|
Adam Havey EVP, Business Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,518
+6.68%
|
-
|
|
Feb 08
2021
|
Robert Kramer President and CEO |
SELL
Open market or private sale
|
Direct |
45,397
-13.71%
|
$5,447,640
$120.03 P/Share
|
|
Feb 08
2021
|
Robert Kramer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,397
+11.87%
|
$1,361,910
$30.75 P/Share
|
|
Jan 21
2021
|
Robert Kramer President and CEO |
SELL
Open market or private sale
|
Direct |
21,900
-13.59%
|
$2,409,000
$110.03 P/Share
|
|
Jan 21
2021
|
Robert Kramer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,900
+11.97%
|
$569,400
$26.45 P/Share
|
|
Jan 20
2021
|
Robert Kramer President and CEO |
SELL
Open market or private sale
|
Direct |
2,232
-1.58%
|
$245,520
$110.0 P/Share
|
|
Jan 20
2021
|
Robert Kramer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,232
+1.55%
|
$58,032
$26.45 P/Share
|
|
Jan 15
2021
|
Robert Kramer President and CEO |
SELL
Open market or private sale
|
Direct |
19,026
-12.02%
|
$2,016,756
$106.01 P/Share
|
|
Jan 15
2021
|
Robert Kramer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,026
+10.73%
|
$475,650
$25.62 P/Share
|